Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation
Immune checkpoint molecules such as programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) have revolutionized the field of lung cancer treatment. As part of our study, we examined the role of these proteins in acute rejection in a mouse model of heterotopic tracheal transplantation. Recipi...
Saved in:
Main Authors: | Taisuke Kaiho (Author), Hidemi Suzuki (Author), Atsushi Hata (Author), Hiroki Matsumoto (Author), Kazuhisa Tanaka (Author), Yuichi Sakairi (Author), Shinichiro Motohashi (Author), Ichiro Yoshino (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ex vivo anchored PD‐L1 functionally prevent in vivo renal allograft rejection
by: Zihuan Luo, et al.
Published: (2022) -
Hypoxia-induced PD-L1 expression and modulation of muscle stem cell allograft rejection
by: Jacob Raiten, et al.
Published: (2024) -
Herbal Components of a Novel Formula PSORI-CM02 Interdependently Suppress Allograft Rejection and Induce CD8+CD122+PD-1+ Regulatory T Cells
by: Chuanjian Lu, et al.
Published: (2018) -
PD-1/PD-L1 Inhibitors in Cervical Cancer
by: Yuncong Liu, et al.
Published: (2019) -
Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
by: Takahiro Aoki, et al.
Published: (2023)